From Wikipedia, the free encyclopedia
Taiho Pharmaceutical (大鵬薬品工業 Taihō Yakuhin Kōgyō ) is a Japanese pharmaceutical company, subsidiary of Otsuka Holdings. It is among the 50 largest in the world by revenue. The company focuses on developing cancer treatments.
- "SRI International to Advance Clinical Development of TAS-108, a Late-Stage Breast Cancer Drug" (Press release). SRI International. Retrieved 2013-02-24.
- "TAS-108: A Better Anti-Estrogen Drug for Treating Breast Cancer". SRI International. Retrieved 2013-02-24.